Lynx1 Capital Management LP Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
7
Insider Buys Sum
$915,440.82
Insider Sells Quantity
1
Insider Sells Sum
$63,952.50

Insider Activity of Lynx1 Capital Management LP

According to the SEC Form 4 filings, Lynx1 Capital Management LP, being in a position of

  1. 10 percent owner at Korro Bio, Inc.,
    оver the last 12 months, has bought 87013 shares for $969,073, and sold 0 shares,
    over all time since 2026-03-31, has bought 87013 shares for $969,073, and sold 0 shares.

Biography of Lynx1 Capital Management LP

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $1,320,70010100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-10-26PurchaseKorro Bio, Inc.
KRRO
10 percent owner
25,124
0.1393%
$11.75$295,091+18.61%
2026-10-23PurchaseKorro Bio, Inc.
KRRO
10 percent owner
2,510
0.0144%
$12.11$30,386+18.53%
2026-10-22PurchaseKorro Bio, Inc.
KRRO
10 percent owner
52,175
0.2634%
$10.72$559,274+16.43%
2026-08-10PurchaseKorro Bio, Inc.
KRRO
10 percent owner
1,462
0.0081%
$13.19$19,279-9.97%
2026-08-06PurchaseKorro Bio, Inc.
KRRO
10 percent owner
5,222
0.0279%
$11.40$59,530+0.99%
2026-06-25PurchasePassage Bio, Inc.
PASG
10 percent owner
50,055
1.4838%
$4.12$206,101+5.08%
2026-03-31PurchaseKorro Bio, Inc.
KRRO
10 percent owner
520
0.0052%
$10.60$5,512+11.31%
2025-12-23PurchaseTScan Therapeutics, Inc.
TCRX
10 percent owner
6,232
0.011%
$0.90$5,602+8.84%
2025-12-22PurchaseTScan Therapeutics, Inc.
TCRX
10 percent owner
75,500
0.1329%
$0.90$67,950+9.72%
2025-12-19PurchaseTScan Therapeutics, Inc.
TCRX
10 percent owner
80,069
0.1416%
$0.90$71,974+10.04%
2025-10-28PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
165,667
0.3048%
$8.40$1.39M+69.26%
2025-10-21PurchaseNeuphoria Therapeutics Inc.
NEUP
10 percent owner
639,110
44.8122%
$5.14$3.28M-14.43%
2025-10-17PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
32,217
0.0544%
$7.84$252,565+81.11%
2025-10-16PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
150,000
0.2573%
$8.86$1.33M+62.7%
2025-10-15PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
51,500
0.0802%
$7.94$409,049+64.77%
2025-10-14PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
15,032
0.0249%
$7.59$114,048+83.72%
2025-10-10PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
277,298
0.467%
$7.36$2.04M+92.09%
2025-10-09PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
626,043
1.0065%
$6.70$4.19M+101.56%
2025-10-08PurchaseCullinan Therapeutics, Inc.
CGEM
10 percent owner
556,300
0.9432%
$6.46$3.59M+119.84%
2025-09-15PurchasePassage Bio, Inc.
PASG
10 percent owner
11,900
0.3765%
$6.99$83,175+6.91%
Total: 35
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.